Home › Combination of a PD-1 antagonist and a 4-1BB agonist for treating cancer

Combination of a PD-1 antagonist and a 4-1BB agonist for treating cancer

US Patent 10899840 · Granted Jan 26, 2021

Estimated economic value: $736,679,000 ⓘ

Assignee